BioCurie is developing an artificial intelligence software platform to better cell and gene therapy.
BioCurie has raised $9.3M in total funding. The most recent round was Grant. The last funding was announced in February 2026.
BioCurie's investors include Advanced Research Projects Agency for Health, Science Center.
BioCurie is headquartered in Wilmington, United States.
BioCurie is developing an artificial intelligence software platform to better cell and gene therapy.
BioCurie is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BioCurie — Funding & Investors." VCBacked, February 11, 2026, https://www.vcbacked.co/company/biocurie. Accessed August 13, 2026.
VCBacked. (2026). BioCurie — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/biocurie
{{cite web |title=BioCurie — Funding & Investors |url=https://www.vcbacked.co/company/biocurie |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated